We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.88T
1-Year Est. Return 44.46%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+0.67%
1 Year Est. Return
+44.46%
3 Year Est. Return
+136.69%
5 Year Est. Return
+180.19%
10 Year Est. Return
+697.06%
AUM
$743B
AUM Growth
+$17B
Cap. Flow
+$20.9B
Cap. Flow %
2.82%
Top 10 Hldgs %
22.73%
Holding
4,944
New
223
Increased
2,961
Reduced
1,210
Closed
86

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$887M
2
AMZN icon
Amazon
AMZN
+$857M
3
AAPL icon
Apple
AAPL
+$844M
4
MSFT icon
Microsoft
MSFT
+$802M
5
TSLA icon
Tesla
TSLA
+$606M

Sector Composition

Rank Sector Weight
1 Technology 24.53%
2 Financials 13.97%
3 Healthcare 13.42%
4 Consumer Discretionary 11.85%
5 Communication Services 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STRR
4651
DELISTED
Star Equity Holdings
STRR
$108K ﹤0.01%
8,014
+556
+7% +$8.3K
DWTX
4652
Dogwood Therapeutics
DWTX
$63.6M
$108K ﹤0.01%
817
+77
+10% +$10.7K
CORZ
4653
DELISTED
Core Scientific, Inc. Common Stock
CORZ
$108K ﹤0.01%
+10,744
New +$108K
TRVG
4654
trivago
TRVG
$373M
$107K ﹤0.01%
8,741
TCRX icon
4655
TScan Therapeutics
TCRX
$49.7M
$106K ﹤0.01%
+12,786
New +$119K
ALIM
4656
DELISTED
Alimera Sciences
ALIM
$106K ﹤0.01%
25,091
ESSC
4657
DELISTED
East Stone Acquisition Corporation Ordinary Shares
ESSC
$106K ﹤0.01%
10,409
MMLP icon
4658
Martin Midstream Partners
MMLP
$96.2M
$105K ﹤0.01%
33,068
+4,359
+15% +$13.3K
ORPH
4659
DELISTED
Orphazyme A/S
ORPH
$105K ﹤0.01%
+25,640
New +$132K
GASS icon
4660
StealthGas
GASS
$333M
$104K ﹤0.01%
39,172
+4,250
+12% +$11.3K
SHIP icon
4661
Seanergy Maritime Holdings
SHIP
$347M
$104K ﹤0.01%
7,209
XTKG
4662
DELISTED
X3 Holdings Co., Ltd. Class A Ordinary Shares
XTKG
0
NYMX
4663
DELISTED
Nymox Pharmaceutical Corp
NYMX
$104K ﹤0.01%
50,731
+9,086
+22% +$16.1K
PPSI
4664
Pioneer Power Solutions
PPSI
$33.1M
$103K ﹤0.01%
31,065
+2,545
+9% +$9.93K
SCLX icon
4665
Scilex Holding
SCLX
$46.1M
$103K ﹤0.01%
295
GVP
4666
DELISTED
GSE Systems, Inc.
GVP
$103K ﹤0.01%
6,994
CLEU
4667
DELISTED
China Liberal Education Holdings
CLEU
$102K ﹤0.01%
+3
New +$133K
ENLV icon
4668
Enlivex Ltd
ENLV
$33.7M
$102K ﹤0.01%
+695
New +$102K
OBIO icon
4669
Orchestra BioMed
OBIO
$252M
$102K ﹤0.01%
10,388
IFMK
4670
DELISTED
iFresh Inc. Common Stock
IFMK
$102K ﹤0.01%
99,336
-27,771
-22% -$32.9K
AUUD
4671
Auddia
AUUD
$6.44M
$101K ﹤0.01%
13
+6
+86% +$66.5K
SOS
4672
SOS Limited
SOS
$15.5M
$101K ﹤0.01%
64
UFAB
4673
DELISTED
Unique Fabricating, Inc.
UFAB
$101K ﹤0.01%
30,623
PANA
4674
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
$101K ﹤0.01%
10,372
MIST icon
4675
Milestone Pharmaceuticals
MIST
$141M
$100K ﹤0.01%
17,576
-3,283
-16% -$18.5K

Similar funds

Geode Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
  • Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
  • Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
  • Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
  • Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
  • Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
  • Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.

Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.